[HTML][HTML] Immune responses following 3rd and 4th doses of heterologous and homologous COVID-19 vaccines in kidney transplant recipients

…, C Seneschall, J Gan, CL Clarke, S Lewis… - …, 2022 - thelancet.com
Background Solid organ transplant recipients have attenuated immune responses to SARS-CoV-2
vaccines. In this study, we report on immune responses to 3rd- (V3) and 4th- (V4) …

Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death

…, A Papadaki, PM Mortimer, NB Buang, S Lewis… - Elife, 2021 - elifesciences.org
End-stage kidney disease (ESKD) patients are at high risk of severe COVID-19. We
measured 436 circulating proteins in serial blood samples from hospitalised and non-hospitalised …

[HTML][HTML] Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescence

…, D Pinheiro, PM Mortimer, S Lewis… - Nature …, 2022 - nature.com
Patients with end-stage kidney disease (ESKD) are at high risk of severe COVID-19. Here,
we perform longitudinal blood sampling of ESKD haemodialysis patients with COVID-19, …

Comparison of humoral and cellular responses in kidney transplant recipients receiving BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines

…, H Edwards, P Mortimer, S McIntyre, S Lewis… - MedRxiv, 2021 - medrxiv.org
Background Attenuated immune responses to mRNA SARS-CoV-2 vaccines have been
reported in solid organ transplant recipients. Most studies have assessed serological responses …

Multi-omics identify LRRC15 as a COVID-19 severity predictor and persistent pro-thrombotic signals in convalescence

…, D Pinheiro, PM Mortimer, S Lewis… - medRxiv, 2022 - medrxiv.org
Patients with end-stage kidney disease (ESKD) are at high risk of severe COVID-19. Here,
we performed longitudinal blood sampling of ESKD haemodialysis patients with COVID-19, …

Longitudinal proteomic profiling of high-risk patients with COVID-19 reveals markers of severity and predictors of fatal disease

…, A Papadaki, PM Mortimer, NB Buang, S Lewis… - MedRxiv, 2020 - medrxiv.org
End-stage kidney disease (ESKD) patients are at high risk of severe COVID-19. We performed
dense serial blood sampling in hospitalised and non-hospitalised ESKD patients with …

Comparative immunogenicity of heterologous versus homologous 3rd SARS-CoV-2 vaccine doses in kidney transplant recipients

…, K Spensley, C Seneschall, J Gan, CL Clarke, S Lewis… - medRxiv, 2022 - medrxiv.org
Background Solid organ transplant recipients have attenuated immune responses to SARS-CoV-2
vaccines. Emerging evidence suggests at least equivalent immunogenicity of …

Multi-omics identify LRRC15 as a COVID-19 severity predictor and persistent pro-thrombotic signals in convalescence (preprint)

…, D Pinheiro, PM Mortimer, S Lewis… - 2022 - pesquisa.bvsalud.org
Patients with end-stage kidney disease (ESKD) are at high risk of severe COVID-19. Here,
we performed longitudinal blood sampling of ESKD haemodialysis patients with COVID-19, …

AGE-RELATED HEARING LOSS IN COMMUNITY PHARMACY: BARRIERS AND FACILITATORS TO COMMUNICATION

P Lewis, S Thomas, J Griffiths, D Phipps… - Innovation in …, 2023 - academic.oup.com
Individuals who have been incarcerated may experience chronic pain due to various reasons,
such as physical injuries sustained during their time in prison, untreated chronic medical …

[HTML][HTML] Capstone Class 4580 Module 2 Peer Responses

S Douglas - onlineclassservices.com
… I completely agree with Shanice’s analysis of the Lewis Blackman case and the importance
of … Shanice effectively highlights the need for a culture of teamwork and collaboration in …